GSK Settles $2.2 Billion Zantac Lawsuit Over Cancer Allegations
In April 2020, the U.S. Food and Drug Administration (FDA) issued a statement alerting patients and healthcare professionals that recent studies have shown that using Zantac is a risk to public health. They also requested the removal of all ranitidine drugs from the market in the form of a voluntary